Drug Trial Radar · NCT07621809
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
570
Planned (sponsor's estimate)
Start
Jul 16, 2026
Primary completion
Aug 15, 2029
Study completion Aug 14, 2033
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Jun 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate the efficacy and safety of ianalumab (VAY736) 300 mg administered subcutaneously (s.c.) monthly for 52 weeks in adult participants with Sjögren's disease who have high symptom burden.
Conditions
- Sjögren´s Disease
Interventions
VAY736Drug
VAY736 once monthly solution for injection for subcutaneous use.
PlaceboDrug
Placebo once monthly solution for injection for subcutaneous use.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in SSSD oral dryness scoreTime frame: Baseline to Week 52
Locations
72 sites in 20 countries. Site status is shown where the registry gives one.
Sun Valley Arthritis Center Ltd
Peoria, Arizona · Recruiting
Unity Health Rheumatology
Searcy, Arkansas · Recruiting
Medvin Clinical Research
Van Nuys, California · Recruiting
Clinical Res Of W Florida
Clearwater, Florida · Recruiting
GNP Research
Cooper City, Florida · Recruiting
Clinical Research of West Florida Inc
Tampa, Florida · Recruiting
Willow Rheumatology Wellness
Willowbrook, Illinois · Recruiting
Tufts Medical Center
Boston, Massachusetts · Recruiting
Clinical Research Inst of MI
Saint Clair Shores, Michigan · Recruiting
Arthritis Rheumatology and Bone Disease Associates PA
Voorhees Township, New Jersey · Recruiting
St Lawrence Health System
Potsdam, New York · Recruiting
On Site Clinical Solutions Llc
Charlotte, North Carolina · Recruiting
Carolina Arthritis Associates
Wilmington, North Carolina · Recruiting
RAO Research LLC
Oklahoma City, Oklahoma · Recruiting
West Tennessee Research Institute
Jackson, Tennessee · Recruiting
Shelby Research LLC
Memphis, Tennessee · Recruiting
Novel Research LLC
Bellaire, Texas · Recruiting
Arthritis Care of Texas
Corpus Christi, Texas · Recruiting
Precision Comprehensive Clinical Research Solutions
Euless, Texas · Recruiting
Abigail Neiman MD PA
Houston, Texas · Recruiting
Accurate Clinical Research
League City, Texas · Recruiting
TEKTON
Leander, Texas · Recruiting
Arthritis Northwest PLLC
Spokane, Washington · Recruiting
Novartis Investigative Site
Maroochydore, Queensland, Australia · Recruiting
Novartis Investigative Site
Graz, Austria · Recruiting
Novartis Investigative Site
São Paulo, São Paulo, Brazil · Recruiting
Novartis Investigative Site
Sydney, Nova Scotia, Canada · Recruiting
Novartis Investigative Site
Rimouski, Quebec, Canada · Recruiting
Novartis Investigative Site
Sherbrooke, Quebec, Canada · Recruiting
Novartis Investigative Site
Beijing, China · Recruiting
Novartis Investigative Site
Beijing, China · Recruiting
Novartis Investigative Site
Beijing, China · Recruiting
Novartis Investigative Site
Jiujiang, China · Recruiting
Novartis Investigative Site
Shenzhen, Guangdong, China · Recruiting
Novartis Investigative Site
Nanjing, Jiangsu, China · Recruiting
Novartis Investigative Site
Taiyuan, Shanxi, China · Recruiting
Novartis Investigative Site
Chengdu, Sichuan, China · Recruiting
Novartis Investigative Site
Wenzhou, Zhejiang, China · Recruiting
Novartis Investigative Site
Ningbo, Zhengjiang, China · Recruiting
Novartis Investigative Site
Bogotá, Colombia · Recruiting
Showing 40 of 72 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.